Dr Reddy's Laboratories announces launch of New Injection in the U.S. Market
Shital Jibhe / 06 Jun 2017
According to IMS Health, The Angiomax brand and generic had US sales of approx $198 million MAT for the most recent 12 months ending in March 2017. Angiomax is a registered trademark of the Medicines Company.
Through a BSE filing on Tuesday, Dr Reddy's Laboratories Limited announced that it has launched Bivalirudin for Injection, 250 mg/
According to IMS Health, The Angiomax brand and generic had US sales of approx $198 million MAT for the most recent 12 months ending in March 2017. Angiomax is a registered trademark of the Medicines Company.
Trading at Rs 2536.65, Dr Reddy's Laboratories Limited was up by Rs 1.70, or 0.07 as of 11.30 on Tuesday, on the BSE. The stock had hit a high of Rs 2543.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.